The latest versions of the Rivian R1S and R1T are about to be eligible for some significant upgrades that can be added through the magic of over-the-air updates. Starting this month, an OTA will be ...
Artur is a copywriter and SEO specialist, as well as a small business owner. In his free time, he loves to play computer games and is glad that he was able to connect his professional career with his ...
When you’re stressed at work, overthinking on a plane, or feeling mildly panicked before a first date, you might catch yourself taking quick, uneven breaths. Before you know it, you’re lightheaded — ...
Objective: To develop and test an interpretable machine learning model that combines clinical data, radiomics, and deep learning features using different regions of interest (ROI) from magnetic ...
Biosensing Instrument Inc (BI) introduces today SPRm 220, a new cell-based surface plasmon resonance (SPR) system. Building on the award-winning SPR microscopy technology first launched in 2017, the ...
TEMPE, Ariz.--(BUSINESS WIRE)--Biosensing Instrument Inc (BI) introduces today SPRm 220, a new cell-based surface plasmon resonance (SPR) system. Building on the award-winning SPR microscopy ...
Lineage Cell Therapeutics has found an experienced hearing loss partner to advance a potentially novel transplant for auditory neurons. William Demant Invest, the largest shareholder of Danish hearing ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf,” cell ...
Blue Protocol: Star Resonance has been fully optimized for mobile devices, featuring a customized user interface tailored for touchscreen gameplay while retaining the same breathtaking visuals and ...
Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now The Chan Zuckerberg Initiative announced ...
Vertex Pharmaceuticals and bluebird bio have entered into an agreement with CMS to participate in a new Medicaid payment model for gene-based sickle cell anemia treatments, the agency announced ...